STAT5 is clearly required for the development of CML since Stat5a/b deletion suppresses disease initiation and maintenance in mouse models of BCR-ABL1-dependent leukemia [19,20]. This evidence concerns the gene STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive.